Peregrine Asset Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.65M Buy
7,214
+4,339
+151% +$4.43M 1.88% 14
2026
Q1
$2.64M Sell
2,875
-28
-1% -$28.4K 0.71% 41
2025
Q4
$3.12M Buy
2,903
+102
+4% +$97.5K 0.88% 36
2025
Q3
$2.14M Buy
2,801
+5
+0.2% +$3.72K 0.64% 47
2025
Q2
$2.18M Buy
2,796
+1
+0% +$777 0.68% 40
2025
Q1
$2.31M Sell
2,795
-32
-1% -$26.6K 0.86% 37
2024
Q4
$2.18M Sell
2,827
-2,910
-51% -$2.41M 0.8% 38
2024
Q3
$5.08M Sell
5,737
-1,859
-24% -$1.67M 1.75% 16
2024
Q2
$6.88M Sell
7,596
-2,030
-21% -$1.62M 2.71% 5
2024
Q1
$7.49M Buy
9,626
+1,519
+19% +$1.08M 2.99% 7
2023
Q4
$4.73M Sell
8,107
-2,797
-26% -$1.63M 2.29% 10
2023
Q3
$5.86M Buy
+10,904
New +$5.62M 3.04% 7
2022
Q2
Sell
-3,821
Closed -$1.09M 104
2022
Q1
$1.09M Buy
3,821
+2,323
+155% +$598K 0.56% 47
2021
Q4
$414K Buy
+1,498
New +$380K 0.17% 80
2020
Q3
Sell
-2,090
Closed -$343K 107
2020
Q2
$343K Sell
2,090
-2,132
-50% -$327K 0.19% 70
2020
Q1
$586K Buy
+4,222
New +$580K 0.44% 44

Other funds holding LLY

Peregrine Asset Advisers's LLY Position: Q2 2026 in Review

Peregrine Asset Advisers increased its Eli Lilly (LLY) stake by 151% in Q2 2026, buying an estimated $4.43M and bringing the position to 7,214 shares worth $8.65M. The position accounts for 1.88% of the portfolio, ranked #14.

Peregrine Asset Advisers first reported a position in LLY in Q1 2020 and has held it in 16 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Peregrine Asset Advisers held 7,214 shares of Eli Lilly worth $8.65M as of Q2 2026.
  • Peregrine Asset Advisers bought 4,339 Eli Lilly shares in Q2 2026, an estimated $4.43M.
  • Eli Lilly made up 1.88% of Peregrine Asset Advisers's portfolio in Q2 2026, its #14 holding.
  • Peregrine Asset Advisers first reported a position in Eli Lilly in Q1 2020 and has held it in 16 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Peregrine Asset Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.